N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide

C31H43N5O5 — CID 58760349

IUPACN-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide
SMILESCC(C)C[C@H](NC(=O)[C@@H]1CCCC[C@@H]1NC(=O)c1cccc(CN2CCCC2)c1)C(=O)c1nn(CC2CC2)c(=O)o1
InChIInChI=1S/C31H43N5O5/c1-20(2)16-26(27(37)30-34-36(31(40)41-30)19-21-12-13-21)33-29(39)24-10-3-4-11-25(24)32-28(38)23-9-7-8-22(17-23)18-35-14-5-6-15-35/h7-9,17,20-21,24-26H,3-6,10-16,18-19H2,1-2H3,(H,32,38)(H,33,39)/t24-,25+,26+/m1/s1
InChIKeyMSQHXOJWOXNXKJ-ZNZIZOMTSA-N
MW565.72 g/mol
LogP3.54
Rot. Bonds12

About N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide

N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide (PubChem CID 58760349) has the molecular formula C31H43N5O5 and a molecular weight of 565.72 g/mol. Its IUPAC name is N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide.

Molecular Properties

Compound NameN-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide
PubChem CID58760349
Molecular FormulaC31H43N5O5
Molecular Weight565.72 g/mol
Exact Mass565.33
IUPAC NameN-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide
SMILESCC(C)C[C@H](NC(=O)[C@@H]1CCCC[C@@H]1NC(=O)c1cccc(CN2CCCC2)c1)C(=O)c1nn(CC2CC2)c(=O)o1
InChIInChI=1S/C31H43N5O5/c1-20(2)16-26(27(37)30-34-36(31(40)41-30)19-21-12-13-21)33-29(39)24-10-3-4-11-25(24)32-28(38)23-9-7-8-22(17-23)18-35-14-5-6-15-35/h7-9,17,20-21,24-26H,3-6,10-16,18-19H2,1-2H3,(H,32,38)(H,33,39)/t24-,25+,26+/m1/s1
InChIKeyMSQHXOJWOXNXKJ-ZNZIZOMTSA-N
XLogP3.54
TPSA126.54 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds12
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500565.72
LogP ≤ 53.54
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide?
The IUPAC name of N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide (CID 58760349) is N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide.
What is the SMILES notation for N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide?
The canonical SMILES for N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide is CC(C)C[C@H](NC(=O)[C@@H]1CCCC[C@@H]1NC(=O)c1cccc(CN2CCCC2)c1)C(=O)c1nn(CC2CC2)c(=O)o1.
What is the InChIKey of N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide?
The InChIKey is MSQHXOJWOXNXKJ-ZNZIZOMTSA-N. The full InChI is InChI=1S/C31H43N5O5/c1-20(2)16-26(27(37)30-34-36(31(40)41-30)19-21-12-13-21)33-29(39)24-10-3-4-11-25(24)32-28(38)23-9-7-8-22(17-23)18-35-14-5-6-15-35/h7-9,17,20-21,24-26H,3-6,10-16,18-19H2,1-2H3,(H,32,38)(H,33,39)/t24-,25+,26+/m1/s1.
What are the key properties of N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide?
N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide has a molecular weight of 565.72 g/mol, XLogP of 3.54, 12 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S,2R)-2-[[(2S)-1-[4-(cyclopropylmethyl)-5-oxo-1,3,4-oxadiazol-2-yl]-4-methyl-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-3-(pyrrolidin-1-ylmethyl)benzamide is sourced from PubChem (CID 58760349), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).